glp-1 gip therapies weight management benefits The Impact of Tirzepatide on Obesity and Diabetes Treatment Revolutionary Incretin Therapy • Tirzepatide is revolutionizing the treatment of obesity and diabetes. 🚀🌟 • Its dual GIP/GLP-1 action leads to more significant GLP-1 Therapy Part 1: Setting

No judgment

Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings

For external use only

Average cost-sharing for a one-month supply of GLP-1 medications ranged from $61 to $93 in 2023

If approved, it will certainly bea case of profoundly delayed gratification. Tough for me not see some level of sour grapes here indeed, the process of drug discovery is complex, long and riddled with failures we now have the amazing biotechnology advances of liraglutide, semaglutide, tirzetapide, and many more to come, that should be celebrated for the millions, to over a billion lives, that can be improved across the world